BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2650583)

  • 21. The management of hypertension in older patients.
    Schnaper HW
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S56-61. PubMed ID: 1691408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of mild to moderate hypertension with ACE inhibitors.
    Taylor SH
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S24-8. PubMed ID: 1691403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the efficacy and safety of quinapril vs. captopril in treatment of moderate to severe hypertension.
    Schnaper HW
    Angiology; 1989 Apr; 40(4 Pt 2):389-95. PubMed ID: 2650582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinapril.
    Materson BJ
    Am J Cardiol; 1992 Apr; 69(10):46C-53C. PubMed ID: 1546639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure. Quinapril/Captopril Congestive Heart Failure Study Group.
    Gavazzi A; Marioni R; Campana C; Montemartini C
    J Hypertens Suppl; 1994 Jul; 12(4):S89-93. PubMed ID: 7965279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinapril in patients with congestive heart failure: controlled trial versus captopril.
    Acanfora D; Furgi G; Trojano L; Picone C; Iannuzzi GL; Rossi M; Papa A; Rengo C; Rengo F
    Am J Ther; 1997; 4(5-6):181-8. PubMed ID: 10423609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.
    Riegger GA
    Eur Heart J; 1991 Jun; 12(6):705-11. PubMed ID: 1830551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy and safety of quinapril in the treatment of moderate to severe and severe hypertension: comparison to captopril.
    Frishman WH
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII26-31. PubMed ID: 2189618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Speed and duration of dose titration with the angiotensin converting enzyme inhibitor quinapril: relationship with efficacy in patients with moderate hypertension.
    Weir MR
    J Hum Hypertens; 1994 Sep; 8(9):725-30. PubMed ID: 7807504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of adverse effects among patients with essential hypertension receiving an ACE inhibitor or a beta-blocker.
    Rosenthal J; Bahrmann H; Benkert K; Baumgart P; Bönner G; Klein G; Neiss A; Schnelle K; Frohlich ED
    Cardiology; 1996; 87(5):409-14. PubMed ID: 8894262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open, parallel group comparison of quinapril and captopril, when added to diuretic therapy, in the treatment of elderly patients with heart failure.
    Beynon JH; Pathy MS
    Curr Med Res Opin; 1997; 13(10):583-92. PubMed ID: 9327193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The Study Group of Quinapril in Arterial Hypertension. The Steering Committee].
    Ambrosioni E; Brusca A; Caponnetto S; Condorelli M; Corea L; Dal Palù C; Fogari R; Mameli P; Mancia G; Neri Serneri GG
    Minerva Cardioangiol; 1992 Mar; 40(3):85-96. PubMed ID: 1630680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
    Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinapril in chronic heart failure.
    Northridge DB; Dargie HJ
    Am J Hypertens; 1990 Nov; 3(11):283S-287S. PubMed ID: 2261147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin converting enzyme inhibitors and the otolaryngologist.
    Cruickshank HE
    Clin Otolaryngol Allied Sci; 1995 Jun; 20(3):189-91. PubMed ID: 7554324
    [No Abstract]   [Full Text] [Related]  

  • 38. Overview of the clinical development of quinapril.
    Frank GJ
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII13-8. PubMed ID: 2189616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator Group.
    Canter D; Frank GJ; Knapp LE; Phelps M; Quade M; Texter M
    J Hum Hypertens; 1994 Mar; 8(3):155-62. PubMed ID: 8006914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hemodynamics effects of ACE inhibitors in the treatment of congestive heart failure.
    Nieminen MS; Kupari M
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S36-40. PubMed ID: 1691405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.